Conjugates for the prevention or treatment of nicotine addiction

Abstract The present invention relates in part to nicotine-derived hapten-carrier conjugates of the formula (111): wherein m, n, W, -(spacer)-, X* and Y are as 5 defined in the description. In certain embodiments, said nicotine-derived hapten carrier conjugates can be used to prepare vaccines for th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	PRYDE, DAVID CAMERON, STEAD, DAVID ROBERT, MERSON, JAMES RICHARD, MEHELIC, PAUL ROBERT, FINNEMAN, JARI IIMARI, JONES, LYN HOWARD, BHATTACHARYA, KESHAB, GERVAIS, DAVID P, DAVIS, HEATHER LYNN, MCCLUSKIE, MICHAEL JOHN, BROWN, ALAN DANIEL, PARSONS, ERIN KRISTEN, THORN, JENNIFER MARIE, ANASTASIOU, NICKOLAS, KOLHE, PARAG ASHOK
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract The present invention relates in part to nicotine-derived hapten-carrier conjugates of the formula (111): wherein m, n, W, -(spacer)-, X* and Y are as 5 defined in the description. In certain embodiments, said nicotine-derived hapten carrier conjugates can be used to prepare vaccines for the treatment and/or prevention of nicotine addiction.